Sure, thank you for the question.
I think there are two points. First of all, I don’t think it is realistic to say that Canadians should not take advantage of confidential prices the way every other drug plan in the world does. It's become a fact of life in the pharmaceutical market. Without passing judgment on whether it's a good thing, I'm of the opinion that it's inevitable. The question is how we get the most people to benefit from this practice. The answer is to have universal coverage. It increases the purchasing power of government, as you heard from Dr. Henry.
If the drug plan is sitting across the table from manufacturers and saying, “It's our price, or you won't be subsidized for Canadians across the country”, that's a strong bargaining position. I think you can have rules around the way these negotiations are conducted that would make them acceptable, but if you're going to have them, you should make sure all Canadians are benefiting from them.
